Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (11): 1749-1754.doi: 10.3969/j.issn.2095-4344.1138

Previous Articles     Next Articles

Cornus officinalis glycosides intervening bone metabolism in rat models of osteoporosis: changes of TRPV6 and TRPV5 pathways

Li Shaoshuo1,Zhao Jingtao1,2,He Changqiang3,Sun Hanqiao4,Ruan Guanlong1   

  1. (1Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China; 2the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China; 3Shenzhen Luohu District Hospital of Traditional Chinese Medicine, Shenzhen 518021, Guangdong Province, China; 4Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, Hubei Province, China)
  • Received:2018-10-27 Online:2019-04-18 Published:2019-04-18
  • Contact: Zhao Jingtao, Master, Associate professor, Associate chief physician, Master’s supervisor, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China; the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China
  • About author:Li Shaoshuo, Master candidate, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong Province, China
  • Supported by:

    the Natural Science Foundation of Guangdong Province, No. S2013010012540 (to ZJT)

Abstract:

BACKGROUND: Regulation of calcium channel directly affects bone metabolism, but the correlation of bone metabolism with TRPV6/TRPV5 pathways remains unclear. Cornus officinalis has been shown to treat and prevent osteoporosis.
OBJECTIVE: To explore the mechanism of Cornus officinalis glycosides underlying intervening the expression of TRPV6 and TRPV5 for preventing and treating osteoporosis.
METHODS: Fifty healthy 6-month-old male Sprague-Dawley rats (provide by Lanoratory Animal Center of Guangzhou University of Chiense Medicine) were selected, weighting (350±15) g. The rats were randomly divided into control (normal saline treatment), model (normal saline treatment), low-, medium, and high-dose Cornus officinalis glycosides groups. The model of osteoporosis was established by bilateral ovariectomy in the latter four groups. The administration was given gastricly, and for 12 weeks. At the end of the experiment, the bone mineral density was detected by dual energy X-ray absorptiometry. The expression levels of TRPV6 and TRPV5 in the right femur were detected by RT-PCR.
RESULTS AND CONCLUSION: The bone mineral density in the Cornus officinalis glycosides groups was significantly higher than that in the model group (P < 0.05). TRPV6 and TRPV5 were expressed in bone tissues of rats in each group. The expression levels of TRPV6 and TRPV5 in all the Cornus officinalis glycosides groups were higher than those in the control and model groups. The medium dose group had the highest expression levels of TRPV6 and TRPV5. The ratio of TRPV6 to TRPV5 and osteogenesis performance in the high-dose group was highest. These results imply that Cornus officinalis glycosides can promote the expression of TRPV6 and TRPV5 in bone tissue of osteoporotic rats, change the ratio of TRPV6 to TRPV5, affect the function of osteoblasts and osteoclasts, promote osteogenesis and improve bone mineral density.

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程

Key words: Cornus, Osteoporosis, Calcium Channels, Tissue Engineering

CLC Number: